Friday, March 27, 2020 8:36:27 AM
She’s head of the Coronavirus Task Force
DR. DEBORAH BRIX: I'm sure you have seen the recent report out of the U.K. about them adjusting completely their needs. This is really quite important. If you remember, that was the report that says there would be 500,000 deaths in the U.K. and 2.2 million deaths in the United States. They've adjusted that number in the U.K. to 20,000. Half a million to 20,000. We are looking at that in great detail to understand that adjustment.
I'm going to say something that is a little bit complicated but do it in a way we can understand it together. In the model, either you have to have a large group of people who a-asymptomatic, who never presented for any test to have the kind of numbers predicted. To get to 60 million people infected, you have to have a large group of a-symptomatics. We have not seen an attack rate over 1 in 1,000. So either we are measuring the iceberg and underneath it, are a large group of people. So we are working hard to get the antibody test and figure out who these people are and do they exist. Or we have the transmission completely wrong.
So these are the things we are looking at, because the predictions of the model don't match the reality on the ground in China, South Korea or Italy. We are five times the size of Italy. If we were Italy and did all those divisions, Italy should have close to 400,000 deaths. They are not close to achieving that.
Models are models. We are -- there is enough data of the real experience with the coronavirus on the ground to really make these predictions much more sound. So when people start talking about 20% of a population getting infected, it's very scary, but we don't have data that matches that based on our experience.
And the situation about ventilators. We are reassured in meeting with our colleagues in New York that there are still I.C.U. Beds remaining and still significant -- over 1,000 or 2,000 ventilators that have not been utilized.
Please for the reassurance of people around the world, to wake up this morning and look at people talking about creating DNR situations, Do Not Resuscitate situations for patients, there is no situation in the United States right now that warrants that kind of discussion. You can be thinking about it in the hospital. Certainly, hospitals talk about this on a daily basis, but to say that to the American people and make the implication that when they need a hospital bed it's not going to be there or a ventilator, it's not going to be there, we don't have evidence of that.
It's our job collectively to assure the American people, it's our job to make sure that doesn't happen. You can see the cases are concentrated in highly urban areas and there are other parts of the states that have lots of ventilators and other parts of New York state that don't have any infected. We can meet the needs by being responsive.
There is no model right now -- no reality on the ground where we can see that 60% to 70% of Americans are going to get infected in the next eight to 12 weeks. I want to be clear about that. We are adapting to the reality on the ground and looking at the models of how they can inform but learning from South Korea and Italy and from Spain and I know you will look up my numbers.
Recent AMRN News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 11:30:10 AM
- Amarin Board of Directors Announces CEO Transition • GlobeNewswire Inc. • 06/04/2024 11:30:00 AM
- Amarin Receives National Reimbursement for VAZKEPA® (icosapent ethyl) in Greece and Announces Exclusive Marketing and Commercialization Agreement with Vianex S.A. • GlobeNewswire Inc. • 05/28/2024 12:15:23 PM
- Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Amarin Reports First Quarter 2024 Business Update and Financial Results • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Amarin Applauds HealthyWomen’s Citizen’s Petition Urging FDA To Take Further Action On Fenofibrate Prescribing in Patients at Risk of Cardiovascular Event • GlobeNewswire Inc. • 04/24/2024 06:00:01 PM
- Amarin Announces Results of Annual General Meeting of Shareholders • GlobeNewswire Inc. • 04/22/2024 12:00:25 PM
- Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024 • GlobeNewswire Inc. • 04/15/2024 12:00:00 PM
- Amarin Highlights Key Data Providing Mechanistic Insights into Eicosapentaenoic Acid (EPA) at ACC.24 • GlobeNewswire Inc. • 04/08/2024 12:00:00 PM
- New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • PR Newswire (Canada) • 04/08/2024 10:30:00 AM
- New REDUCE-IT® Analyses Show VASCEPA®/VAZKEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups • GlobeNewswire Inc. • 04/06/2024 07:30:00 PM
- Amarin Provides Update on VAZKEPA® (Icosapent Ethyl) Intellectual Property Portfolio in Europe • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Research Evaluating Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the American College of Cardiology’s (ACC) Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 03/04/2024 10:30:53 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/04/2024 01:00:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 12:06:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 12:05:56 PM
- Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference on February 29, 2024 • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/12/2024 01:00:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:31:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/09/2024 09:30:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2024 09:30:22 PM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM